TBIO Stock ( Bio surges in after hours on report of Sanofi bid ) Price prediction

MAKE SURE YOU JOIN OUR 🔥NEW🔥 DISCORD

ITS CALLED MAKING EASY MONEY link below👇👇
https://discord.gg/4WyYRrSd

Sanofi SASY.PA has offered to buy U.S. biotech company Translate Bio TBIO.O, two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race.

An offer for all Translate Bio shares had been made to the U.S. group's shareholders, the sources said. The persons declined to be identified due to the confidentiality of the talks.

Translate's board was expected to meet later on Monday to discuss the offer, one of the sources said. The second source said Sanofi's directors had met on Sunday to discuss the potential deal.
Translate's board was expected to meet today to discuss the bid, according to a Reuters report. Sanofi's board met on Sunday to talk about the possible deal. Terms of the bid weren't known.
Last March, Sanofi and Translate Bio added an mRNA vaccine for COVID-19 to their 2018 collaboration aimed at developing vaccines for infectious diseases. Last month, the companies initiated a Phase 1 clinical trial evaluating an mRNA-based investigational vaccine against seasonal influenza.
Last week, Translate Bio climbs to a five-month high after Street-high target from Roth.
Translate Bio has a $2.08B market cap compared to $142.B and $79/3.1B in recent S&P 500 component Moderna (NASDAQ:MRNA) and Pfizer’s (NYSE:PFE) German partner in COVID-19 vaccine development, BioNTech (NASDAQ:BNTX), respectively.